ALDH1A1 and adenocarcinoma: Thus, in this study, the cytotoxicity of a subset of adrenoceptor blockers exhibiting varying selectivity toward adrenoceptors was examined against NSCLC adenocarcinoma cell lines A549 and H1299, cells expressing high and low levels of ALDH1A1, respectively [59,60].